- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05686499
Building Capacity for Screening & Early Diagnosis of Colorectal Cancer Through a Comprehensive Colonoscopy Training Program in Nigeria
This protocol seeks to develop a colonoscopy training program in Nigeria in order to increase the number of health care providers proficient in colonoscopy. The goal is to improve capacity for screening and early diagnosis of colorectal cancer (CRC) by training and expanding the healthcare workforce that is competent in endoscopy techniques. The project has three components, a needs assessment, simulation training, and training on live patients.
The first part of this project determines the number of providers and endoscopy procedures currently performed in Nigeria, as well as patient access to facilities that have colonoscopy capabilities, through a mixed methods approach. Surveys, focus in-depth interviews with key stakeholders, and use geographic information system (GIS) modeling technology will be employed to perform a needs assessment. The second component of this project investigates whether a locally developed low fidelity (LF) simulation colonoscopy training model is an effective teaching, training, and assessment tool for skill acquisition and confidence compared to a high-fidelity (HF) colonoscopy model. The third component of this project is training healthcare providers on real patients who have an indication for colonoscopy. This project seeks to build capacity for endoscopy services in order to increase capacity for screening and early diagnosis of CRC. At the end of the project, it is expected the number of providers trained to perform colonoscopy in a resource limited setting like Nigeria will increase.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The goal of this project is to build capacity for early diagnosis of CRC by developing a comprehensive colonoscopy training program that could in the future lead to credentialing and accreditation of a trainee. The first aspect of the project focuses on needs assessment analysis as it determines the quantity of providers and access to facilities that perform colonoscopy through surveys, focus in-depth interviews, and GIS technology. The second component investigates whether a locally developed LF simulation colonoscopy training tool is an effective teaching, training, and assessment tool for skill acquisition and confidence compared to a HF colonoscopy model in a resource limited setting. The third component of the project will assess whether training on a low or high-fidelity simulator then translates to improved performance of colonoscopy on live patients. At the end of the project, it is expected the number of providers trained to perform colonoscopy in a resource limited setting like Nigeria will increase.
OVERVIEW OF STUDY DESIGN/INTERVENTION A mixed methods survey was developed that determines the baseline number of endoscopists, nurses, anaesthetists, ancillary staff, costs, and the number of procedures performed per year in endoscopy centers in the country of Nigeria. This survey will be developed with qualitative specialists at the Obafemi Awolowo University (OAU) and the Memorial Sloan Kettering Cancer Center (MSKCC). Healthcare professionals who are part of Nigerian medical societies will be invited to participate in the survey through paper, electronic, or social media platforms. Focused in-depth interviews with key stakeholders will be conducted to further understand the barriers to endoscopy care in Nigeria.
Prior to participating in this survey study, the purpose of the study will be explained to potential participants. They will be provided information about the research study in written form and a consent form will be provided. Consent will be obtained in written form in English, since this is the national language medium used for medical professionals in Nigeria.
Results from this survey and collaborations with medical societies in Nigeria, will provide information needed to identify which healthcare facilities perform endoscopy in Nigeria. GIS technology will be utilized to analyze patient access to these facilities based on locations of facilities to neighborhoods where patients may reside. Qualitative surveys and focus interviews with key stakeholders will also provide information on barriers to accessing and providing care to patients who need colonoscopy.
For the simulation training portion of the study, following initial recruitment, an equal number of consented participants will be randomized to learn colonoscopy on high or low fidelity models. The HF simulator will be Limbs and Things Colonoscopy Training Model product KKM40. The LF simulator will be made in Nigeria, based on low fidelity models that have been published in the literature. Prior to beginning the course, the participants will be given instructions, a prior experience and confidence survey, and then will be asked to perform colonoscopy. This first assessment will serve as a baseline measure of colonoscopy skills. The LF group will perform a pretest on LF models, and the HF group will perform the pre-test on HF models. Participants will be evaluated utilizing the Mayo colonoscopy skills assessment tool and the Global Assessment of Gastrointestinal Endoscopic Skills (GAGES) tools that have been validated and published in the literature previously.
Following this pre-test, study participants will partake in didactic teaching sessions. The colonoscopy lecture curriculum will be adapted for the Nigerian context and standardized utilizing content based on the American Board of Surgery Flexible Endoscopy curriculum for general surgery residents, general surgery resident curriculum (SCORE) endoscopy module, and the Joint Advisory group on GI Endoscopy program. Teaching sessions between high and low fidelity groups will be identical except for the type of simulation models used to demonstrate and practice colonoscopy. Trainees will have the opportunity to practice colonoscopy on simulators with immediate feedback from instructors.
After this 4-6-hour teaching session, participants will take a post-test identical to the colonoscopy pre-test. The next day participants will perform colonoscopy procedures on live patients and be evaluated on live patients utilizing the GAGES and mayo colonoscopy skills assessment tools. Additionally, at the end of the study, participants will be asked to fill out a confidence survey During the live patient sessions, the study will involve patients who were scheduled to undergo a clinically indicated colonoscopy. The patients will sign a consent form to be part of the study which allows trainees to perform colonoscopy under the direct supervision by trained colonoscopy physician. The trainee will be the primary endoscopist under the supervision of a faculty endoscopy evaluator. The evaluator will allow the study participants independence while ensuring patient safety. The instructor can provide verbal instruction if necessary. If the instructors feel the study participant is not making progress or if patient safety is of concern, the instructors are permitted to take control of the colonoscopy and navigate through difficult portions of the colon or takeover the procedure completely. The maximum time that will be allotted for the trainee to complete the colonoscopy will be 30 minutes. A critical flaw point will be given to the trainee participant if complete takeover occurs, although they will be given the opportunity to try again on a different patient if feasible.
Trainees will also be evaluated based on total procedure time, time to rectosigmoid junction, splenic flexure, hepatic flexure and cecal intubation, % of successful cecal intubation, % of time for which the view of the lumen was lost, % of times TI intubation successful, and withdrawal time of colonoscopy from cecum, avoidance of bowel perforation and median depth of maximal insertion based on the following scale: 1 = rectum, 2 = sigmoid, 3 = descending colon, 4 = splenic flexure, 5 = transverse colon, 6 = hepatic flexure, 7 = ascending colon, 8 = cecum. Additionally, at the end of the study, participants will be asked to fill out course satisfaction and confidence surveys.
PRIMARY AND SECONDARY OUTCOMES Primary Outcome: To determine whether learning colonoscopy on a LF simulation model confers similar skill acquisition and confidence as training on a HF model Secondary Outcomes: Determine access to endoscopists and endoscopy facilities barriers to endoscopy, and costs of endoscopy in Nigeria. Assess whether training on a low or high-fidelity simulator improves colonoscopy performance on real patients. To evaluate the overall improvement in technical skills of trainees before and after delivery of a simulation-based colonoscopy training program designed to teach colonoscopy in a resource limited setting. Investigators will also determine costs of implementing a colonoscopy training program as well as costs of endoscopy at each of the facilities.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Osun
-
Ile Ife, Osun, Nigeria, 220005
- Recruiting
- Endoscopy Unit, Obafemi Awolowo University Teaching Hospitals
-
Contact:
- Olusegun I Alatise, FWACS
- Phone Number: 2348033859387
- Email: segunalatishe@gmail.com
-
Ile-Ife, Osun, Nigeria, 220005
- Recruiting
- Obafemi Awolowo University Teaching Hospitals Complex
-
Contact:
- Olusegun I. Alatise, MD
- Phone Number: +2348033859387
- Email: segunalatishe@gmail.com
-
Contact:
- Funmilola O. Wuraola, MD
- Phone Number: +2348032287556
- Email: wuraie@yahoo.com
-
Contact:
- Shilpa S. Murthy, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age >18
- Health care professionals will include consultants and registrars in medicine, surgery, and gastroenterology
Exclusion Criteria:
- Participants under the age of 18
- Participants unwilling to sign consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: High Fidelity (HF) Arm
The HF simulator will be Limbs and Things Colonoscopy Training Model product KKM40.
|
|
|
Experimental: Low Fidelity (LF) Arm
The LF simulator will be made in Nigeria, based on low fidelity models that have been published in the literature
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ratio of low-fidelity simulator trained endoscopists with improved colonoscopy performance on real patients to high-fidelity simulator trained endoscopists with improved performance on real patients
Time Frame: 5 days
|
proportion of LF simulator training who can perform colonoscopy adequately on live patient to proportion of HF simulator training who can perform colonoscopy adequately on live patients
|
5 days
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ERC/2022/07/03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colon Cancer
-
Chaoxi ZhouRecruitingProximal Transverse Colon Cancer | Ascending Colon CancerChina
-
National Cancer Institute (NCI)NSABP Foundation IncCompletedColon Adenocarcinoma | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIA Colon Cancer AJCC v7 | Stage IIB Colon Cancer AJCC v7 | Stage IIC Colon Cancer AJCC v7United States
-
Gruppo Oncologico del Nord-OvestSeagen Inc.; Servier; Foundation MedicineSuspendedStage II Colon Cancer | Stage III Colon Cancer | HER2-positive Colon Cancer | RAS Wild-type Colon CancerItaly
-
Chang Gung Memorial HospitalCompletedColon Cancer | Cancer Recurrence | Colon Adenocarcinoma | Colon Cancer Stage II | Colon Cancer Stage I | Survival Analysis | Colon Cancer Stage IIITaiwan
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedFatigue | Depressive Symptoms | Stage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Psychosocial Effects of Cancer and Its Treatment | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage I Colon Cancer | Stage... and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage III Colon Cancer AJCC v8 | Colon Adenocarcinoma | Microsatellite Stable Colon Carcinoma | Stage IIB Colon Cancer AJCC v8 | Stage IIC Colon Cancer AJCC v8United States
-
Hospital da Senhora da OliveiraCompletedColon Cancer | Colon Adenoma | Colon Polyp | Colon Rectal CancerPortugal
-
National Cancer Institute (NCI)CompletedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer | Stage IVB Colon Cancer | Stage IVB Rectal CancerUnited States
Clinical Trials on Didactic Lectures and demonstrations
-
University of FloridaWithdrawnKnowledge, Attitudes, Practice | Behavior
-
Institut de Recherche en Sciences de la Sante,...Institute of Tropical Medicine, Belgium; Micronutrient Initiative; Terre des...CompletedGrowth Failure | Good Infant and Young Child Feeding PracticesBurkina Faso
-
Universidade Federal de PernambucoCompleted
-
Case Western Reserve UniversityNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
International Islamic University, IslamabadRecruitingImpulsivity | Suicidal Ideation and BehaviorPakistan
-
Brigham and Women's HospitalKlinikum Nürnberg; Institut fuer Notfallmedizin Kempten e.V., GermanyCompleted
-
Hunter College of City University of New YorkWeill Medical College of Cornell University; Children's AidCompletedObesity, ChildhoodUnited States
-
University of JazanCompletedAge-related Cognitive DeclineSaudi Arabia
-
Tufts UniversityWashington University School of Medicine; University of Massachusetts, Amherst and other collaboratorsRecruitingObesity, ChildhoodUnited States
-
University of TorontoUnknownPrimary Care Genetics | Hereditary Colorectal CancerCanada